DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $321,000 | -82.4% | 15,908 | -67.4% | 0.01% | -81.0% |
| Q2 2021 | $1,821,000 | +40.0% | 48,806 | -4.1% | 0.06% | +31.8% |
| Q1 2021 | $1,301,000 | +55.1% | 50,897 | +33.6% | 0.04% | +57.1% |
| Q4 2020 | $839,000 | -4.0% | 38,095 | -21.6% | 0.03% | -12.5% |
| Q3 2020 | $874,000 | -30.0% | 48,591 | -1.2% | 0.03% | -33.3% |
| Q2 2020 | $1,249,000 | +21.6% | 49,186 | -12.0% | 0.05% | +20.0% |
| Q1 2020 | $1,027,000 | -31.1% | 55,912 | -17.4% | 0.04% | -16.7% |
| Q4 2019 | $1,491,000 | – | 67,662 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |